Market Research Logo

A Product and Pipeline Analysis of the Opioid Therapeutics and Drug Delivery Market

A Product and Pipeline Analysis of the Opioid Therapeutics and Drug Delivery Market

This research service focuses on the global opioid therapeutics market with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review, and key opinion leader (KOL) commentary.

A pipeline assessment is provided for all active candidates in development.

The information contained in this research service was derived from published sources including the following: Disease organization websites; Frost & Sullivan publications, including annual research studies; Securities and Exchange Commission (SEC) filings and press releases; United States government public sources; and scientific journals.

About this report

This market insight provides data for the Global Opioid Therapeutics market. The analysis looks at opioid pharmaceutical pipeline drugs currently in the market and drugs that are in Phase III stage, which pose a potential threat to competitors. It also offers a competitive analysis of the drugs, and the forecast outcome and impact of each of these drugs. Opioid drugs in the current market have a space for tamper-resistant formulations. The opioids market is segmented into relapsing neuropathic pain, acute and post-operative pain, cancer-induced pain, and moderate to severe chronic pain.


  • Methodology and Scope
  • Executive Summary
  • Introduction
    • Physician Guidelines to Opioid Therapy-Moderate to Severe Chronic Pain
    • Physician Guidelines to Opioid Therapy-Neuropathic Pain
    • Physician Guidelines to Opioid Therapy-Cancer-induced Pain
    • Physician Guidelines to Opioid Therapy-Acute and Post-operative Pain
  • US Opioid Therapeutics Market Overview
    • Introduction-Chronic Pain Prevalence by Severity
    • Opioid Pain Market by Region
    • Top-selling Products in the US Opioid Therapeutics Market
      • Table Opioid Therapeutics Market: Top-selling Products, US, 2013
    • Opioid Therapeutics-Percent Sales by Type of Pain
    • Opioid Therapeutics-Pain Formulation Prescription Sales
    • Opioid Therapeutics-TRF and Non-TRF Prescription Sales
    • Opioid Therapeutics-Estimated Peak Sales by Route of Administration
    • Opioid Therapeutics Market-Pain Patch Products
    • Game-changing Strategies
    • Companies to Watch
  • Competitive Landscape
    • Opioid Therapeutics Market-Competitive Landscape
    • Marketed Product Synopsis-Moderate to Severe Chronic Pain Opioid Therapeutics Market
    • Pipeline Analysis-Moderate to Severe Chronic Pain Opioid Therapeutics
    • Marketed Product-Neuropathic Pain Opioid Therapeutics
    • Pipeline Analysis-Neuropathic Pain Opioid Therapeutics
    • Marketed Product Synopsis-Cancer-induced Pain Opioid Therapeutics
    • Pipeline Analysis-Cancer-induced Pain Opioid Therapeutics
    • Marketed Product Synopsis-Post-operative and Acute Pain Opioid Therapeutics
    • Pipeline Analysis-Post-operative and Acute Pain Opioid Therapeutics
    • Moderate to Severe Chronic Pain Clinical Trial Design Comparison-Phase 3
    • Cancer-induced Pain Clinical Development Synopsis-Phase 3
    • Post-operative and Acute Pain Clinical Trial Design Comparison-Phase 3
  • Timeline Transparency
    • Estimated US Product Launch Timeline
    • Pre-launch Products Clinical Program-Remoxy and HYD Tablets
    • Pipeline Products Clinical Phase 3 Studies-BEMA Buprenorphine, COL-003, Nucynta
    • Pipeline Products Clinical Phase 3 Studies-Zalviso
  • Late-stage Development-Product Dashboards
    • Product Dashboard: Remoxy (Durect/Pain Therapeutics)
    • Product Dashboard: BEMA Buprenorphine (Endo Pharmaceuticals/Biodelivery)
    • Product Dashboard: HYD Tablet (Purdue Pharma)
    • Product Dashboard: COL-003/Oxycodone DETERx (Collegium)
    • Product Dashboard: Nucynta Extended Release (Grünenthal/J&J)
    • Product Dashboard: MoxDuo Immediate Release (Actavis/QRxPharma)
  • The Last Word

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report